IVOZFO Trademark

Trademark Overview

On Thursday, October 24, 2019, a trademark application was filed for IVOZFO with the United States Patent and Trademark Office. The USPTO has given the IVOZFO trademark a serial number of 88666761. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2024. This trademark is owned by Verity Pharmaceuticals Inc.. The IVOZFO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for the treatment of infectious diseases, namely, osteomyelitis, urinary tract infections, respiratory tract infections, meningitis and bacteremia
ivozfo

General Information

Serial Number88666761
Word MarkIVOZFO
Filing DateThursday, October 24, 2019
Status700 - REGISTERED
Status DateTuesday, September 3, 2024
Registration Number7490922
Registration DateTuesday, September 3, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for the treatment of infectious diseases, namely, osteomyelitis, urinary tract infections, respiratory tract infections, meningitis and bacteremia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVerity Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga L4W4Y9
CA
Party NameVerity Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga L4W4Y9
CA
Party NameVerity Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga L4W4Y9
CA

Trademark Events

Event DateEvent Description
Thursday, January 30, 2020NON-FINAL ACTION E-MAILED
Monday, October 28, 2019NEW APPLICATION ENTERED
Wednesday, October 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 30, 2020ASSIGNED TO EXAMINER
Thursday, January 30, 2020NON-FINAL ACTION WRITTEN
Thursday, January 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 27, 2020ASSIGNED TO LIE
Wednesday, July 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 31, 2020SUSPENSION LETTER WRITTEN
Friday, July 31, 2020LETTER OF SUSPENSION E-MAILED
Friday, July 31, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 1, 2021SUSPENSION INQUIRY WRITTEN
Monday, February 1, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, February 1, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, July 19, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 2, 2021SUSPENSION LETTER WRITTEN
Monday, August 2, 2021LETTER OF SUSPENSION E-MAILED
Monday, August 2, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 2, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, February 2, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 2, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, July 1, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 7, 2022ASSIGNED TO LIE
Thursday, July 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2023SUSPENSION LETTER WRITTEN
Monday, January 9, 2023LETTER OF SUSPENSION E-MAILED
Monday, January 9, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 14, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, August 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 11, 2022SUSPENSION LETTER WRITTEN
Monday, July 11, 2022LETTER OF SUSPENSION E-MAILED
Monday, July 11, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 10, 2023SUSPENSION INQUIRY WRITTEN
Monday, July 10, 2023INQUIRY TO SUSPENSION E-MAILED
Monday, July 10, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, August 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2023SUSPENSION LETTER WRITTEN
Tuesday, August 15, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, August 15, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 12, 2024SUSPENSION INQUIRY WRITTEN
Monday, February 12, 2024INQUIRY TO SUSPENSION E-MAILED
Monday, February 12, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, May 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 9, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, May 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

ivozfo pharmaceutical tract namely preparations infections meningitis bacteremia urinary respiratory diseases